Drosophila eyes absent is a novel mRNA target of the Tristetraprolin (TTP) protein DTIS11

International Journal of Biological Sciences

Volumn 8, Issue 5, 2012, Pages 606-619

  Yeh, Po An ^a   Yang, Wen Hsuan ^b   Chiang, Pei Yu ^b   Wang, Shun Chang ^c   Chang, Mau Sun ^b,c   Chang, Ching Jin ^b,c  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

Author keywords

AU rich element; Drosophila; Eyes absent; RNA stability; Tristetraprolin

Indexed keywords

DROSOPHILA PROTEIN; DTISII PROTEIN, DROSOPHILA; EYA2 PROTEIN, HUMAN; EYE PROTEIN; EYES ABSENT PROTEIN, DROSOPHILA; MESSENGER RNA; NUCLEAR PROTEIN; PROTEIN TYROSINE PHOSPHATASE; SIGNAL PEPTIDE; TRISTETRAPROLIN;

3' UNTRANSLATED REGION; AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CELL SURVIVAL; DOWN REGULATION; DROSOPHILA MELANOGASTER; FEMALE; GENETICS; HUMAN; METABOLISM; MOUSE; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; RNA STABILITY; SEQUENCE ALIGNMENT; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CELL SURVIVAL; DOWN-REGULATION; DROSOPHILA MELANOGASTER; DROSOPHILA PROTEINS; EYE PROTEINS; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; NUCLEAR PROTEINS; PROTEIN TYROSINE PHOSPHATASES; RNA STABILITY; RNA, MESSENGER; SEQUENCE ALIGNMENT; TRISTETRAPROLIN;

DROSOPHILA MELANOGASTER; MAMMALIA;

EID: 84863759889     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.3782     Document Type: Article

References (55)

1. Fan J, Yang X, Wang W, et al. Global analysis of stress-regulated mRNA turnover by using cDNA arrays. Proc Natl Acad Sci U S A. 2002; 99(16):10611-16.
2. Chen CY, Shyu AB. AU-rich elements: characterization and im-portance in mRNA degradation. Trends Biochem Sci. 1995; 20(11):465-70.
3. Blackshear PJ. Tristetraprolin and other CCCH tandem zinc-finger proteins in the regulation of mRNA turnover. Biochem Soc Trans. 2002; 30(Pt 6):945-52.
4. Baou M, Jewell A, Murphy JJ. TIS11 family proteins and their roles in posttranscriptional gene regulation. J Biomed Biotechnol. 2009;: 634520.
5. Blackshear PJ, Phillips RS, Ghosh S, et al. Zfp36l3, a rodent X chromosome gene encoding a placenta-specific member of the Tristetraprolin family of CCCH tandem zinc finger proteins. Biol Reprod. 2005; 73(2):297-307.
6. Lai WS, Blackshear PJ. Interactions of CCCH zinc finger proteins with mRNA: tristetraprolin-mediated AU-rich element-dependent mRNA degradation can occur in the absence of a poly(A) tail. J Biol Chem. 2001; 276(25):23144-54.
7. Lai WS, Kennington EA, Blackshear PJ. Tristetraprolin and its fam-ily members can promote the cell-free deadenylation of AU-rich element-containing mRNAs by poly(A) ribonuclease. Mol Cell Biol. 2003; 23(11):3798-812.
8. Carballo E, Lai WS, Blackshear PJ. Feedback inhibition of macro-phage tumor necrosis factor-alpha production by tristetraprolin. Science 1998; 281(5379):1001-5.
9. Carballo E, Lai WS, Blackshear PJ. Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colo-ny-stimulating factor messenger RNA deadenylation and stability. Blood 2000; 95(6):1891-9.
10. Lauwers A, Twyffels L, Soin R, et al. Post-transcriptional Regulation of Genes Encoding Anti-microbial Peptides in Drosophila. J Biol Chem. 2009; 284(13):8973-83.
11. Wei Y, Xiao Q, Zhang T, et al. Differential regulation of mRNA stability controls the transient expression of genes encoding Dro-sophila antimicrobial peptide with distinct immune response char-acteristics. Nucleic Acids Res. 2009; 37(19):6550-61.
12. Baou M, Jewell A, Muthurania A, et al. Involvement of Tis11b, an AU-rich binding protein, in induction of apoptosis by rituximab in B cell chronic lymphocytic leukemia cells. Leukemia 2009; 23(5):986-9.
13. Johnson BA, Blackwell TK. Multiple tristetraprolin sequence do-mains required to induce apoptosis and modulate responses to TNFalpha through distinct pathways. Oncogene 2002; 21(27):4237-46.
14. Johnson BA, Geha M, Blackwell TK. Similar but distinct effects of the tristetraprolin/TIS11 immediate-early proteins on cell survival. Oncogene 2000; 19(13):1657-64.
15. Kim CW, Kim HK, Vo MT, et al. Tristetraprolin controls the stability of cIAP2 mRNA through binding to the 3'UTR of cIAP2 mRNA. Biochem Biophys Res Commun. 2010; 400(1):46-52.
16. Lee SK, Kim SB, Kim JS, et al. Butyrate response factor 1 enhances cisplatin sensitivity in human head and neck squamous cell carci-noma cell lines. Int J Cancer 2005; 117(1):32-40.
17. Lai WS, Parker JS, Grissom SF, et al. Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts. Mol Cell Biol. 2006; 26(24):9196-208.
18. Stoecklin G, Tenenbaum SA, Mayo T, et al. Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin. J Biol Chem. 2008; 283(17):11689-99.
19. Emmons J, Townley-Tilson WH, Deleault KM, et al. Identification of TTP mRNA targets in human dendritic cells reveals TTP as a critical regulator of dendritic cell maturation. RNA 2008; 14(5):888-902.
20. Cairrao F, Halees AS, Khabar KS, et al. AU-rich elements regulate Drosophila gene expression. Mol Cell Biol. 2009; 29(10):2636-43.
21. Chen YL, Huang YL, Lin NY, et al. Differential regulation of ARE-mediated TNFalpha and IL-1beta mRNA stability by lipopol-ysaccharide in RAW264.7 cells. Biochem Biophys Res Commun. 2006; 346(1):160-68.
22. Lin NY, Lin CT, Chen YL, et al. Regulation of tristetraprolin during differentiation of 3T3-L1 preadipocytes. FEBS J. 2007; 274(3):867-78.
23. Wolff T, Ready DF. Cell death in normal and rough eye mutants of Drosophila. Dev. 1991; 113(3):825-39.
24. Brachmann CB, Cagan RL. Patterning the fly eye: the role of apop-tosis. Trends Genet. 2003; 19(2):91-6.
25. McGuire SE, Roman G, Davis RL. Gene expression systems in Drosophila: a synthesis of time and space. Trends Genet. 2004; 20(8):384-91.
26. Franks TM, Lykke-Andersen J. TTP and BRF proteins nucleate pro-cessing body formation to silence mRNAs with AU-rich elements. Genes Dev. 2007, 21(6):719-35.
27. Bonini NM, Leiserson WM, Benzer S: The eyes absent gene: genetic control of cell survival and differentiation in the developing Dro-sophila eye. Cell 1993; 72(3):379-95.
28. Bessa J, Gebelein B, Pichaud F, et al. Combinatorial control of Dro-sophila eye development by Eyeless, Homothorax, and Teashirt. Genes Dev. 2002; 16:2415-7.
29. Zhang L, Yang N, Huang J, et al. Transcriptional coactivator Dro-sophila eyes absent homologue 2 is up-regulated in epithelial ovarian cancer and promotes tumor growth. Cancer Res. 2005; 65(3):925-32.
30. Farabaugh SM, Micalizzi DS, Jedlicka P, et al. Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-beta signaling, epithelial-mesenchymal transition, and cancer stem cell properties. Oncogene 2012; 31(5):552-62.
31. Cook PJ, Ju BG, Telese F, et al. Tyrosine dephosphorylation of H2AX modulates apoptosis and survival decisions. Nature 2009; 458(7238):591-6.
32. Rogakou EP, Nieves-Neira W, Boon C, et al. Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139. J Biol Chem. 2000; 275(13):9390-5.
33. Mukherjee B, Kessinger C, Kobayashi J, et al. DNA-PK phosphory-lates histone H2AX during apoptotic DNA fragmentation in mammalian cells. DNA Repair. 2006; 5(5):575-90.
34. Leiserson WM, Benzer S, Bonini NM. Dual functions of the Dro-sophila eyes absent gene in the eye and embryo. Mech Dev. 1998; 73(2):193-202.
35. Bonini NM, Leiserson WM, Benzer S. Multiple roles of the eyes absent gene in Drosophila. Dev biol. 1998; 196(1):42-57.
36. Jemc J, Rebay I. The eyes absent family of phosphotyrosine phos-phatases: properties and roles in developmental regulation of tran-scription. Ann Rev Biochem. 2007; 76:513-38.
37. Li X, Oghi KA, Zhang J, et al. Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian or-ganogenesis. Nature 2003; 426(6964):247-54.
38. Brennan SE, Kuwano Y, Alkharouf N, et al. The mRNA-destabilizing protein tristetraprolin is suppressed in many cancers, altering tumorigenic phenotypes and patient prognosis. Cancer Res. 2009; 69(12):5168-76.
39. Al-Souhibani N, Al-Ahmadi W, Hesketh JE, et al. The RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs in-volved in breast cancer-related processes. Oncogene 2010; 29(29):4205-15.
40. Suswam E, Li Y, Zhang X, et al. Tristetraprolin down-regulates interleukin-8 and vascular endothelial growth factor in malignant glioma cells. Cancer Res. 2008; 68(3):674-82.
41. Li CM, Guo M, Borczuk A, et al. Gene expression in Wilms' tumor mimics the earliest committed stage in the metanephric mesen-chymal-epithelial transition. Am J Pathol. 2002; 160(6):2181-90.
42. Miller SJ, Lan ZD, Hardiman A, et al. Inhibition of Eyes Absent Homolog 4 expression induces malignant peripheral nerve sheath tumor necrosis. Oncogene 2010; 29(3):368-79.
43. Pandey RN, Rani R, Yeo EJ, et al. The Eyes Absent phospha-tase-transactivator proteins promote proliferation, transformation, migration, and invasion of tumor cells. Oncogene 2010; 29(25):3715-22.
44. Treisman JE, Rubin GM. Targets of glass regulation in the Dro-sophila eye disc. Mech Dev. 1996; 56(1-2):17-24.
45. Essafi-Benkhadir K, Onesto C, Stebe E, et al. Tristetraprolin inhibits Ras-dependent tumor vascularization by inducing vascular endo-thelial growth factor mRNA degradation. Mol Biol Cell 2007; 18(11):4648-58.
46. Marchese FP, Aubareda A, Tudor C, et al. MAPKAP kinase 2 blocks tristetraprolin-directed mRNA decay by inhibiting CAF1 dead-enylase recruitment. J Biol Chem. 2010; 285(36):27590-600.
47. Clement SL, Scheckel C, Stoecklin G, et al. Phosphorylation of tristetraprolin by MK2 impairs AU-rich element mRNA decay by preventing deadenylase recruitment. Mol Cell Biol. 2011; 31(2):256-66.
48. Sandler H, Kreth J, Timmers HT, et al. Not1 mediates recruitment of the deadenylase Caf1 to mRNAs targeted for degradation by tristetraprolin. Nucleic Acids Res. 2011; 39(10):4373-86.
49. Lykke-Andersen J, Wagner E. Recruitment and activation of mRNA decay enzymes by two ARE-mediated decay activation domains in the proteins TTP and BRF-1. Genes Dev. 2005; 19(3):351-61.
50. Hau HH, Walsh RJ, Ogilvie RL, et al. Tristetraprolin recruits func-tional mRNA decay complexes to ARE sequences. J Cell Biochem. 2007; 100(6):1477-92.
51. Kedar VP, Darby MK, Williams JG, et al. Phosphorylation of human tristetraprolin in response to its interaction with the Cbl interacting protein CIN85. PLoS One 2010; 5(3):e9588.
52. Twizere JC, Kruys V, Lefebvre L, et al. Interaction of retroviral Tax oncoproteins with tristetraprolin and regulation of tumor necrosis factor-alpha expression. J Natl Cancer Inst. 2003; 95(24):1846-59.
53. Taylor GA, Carballo E, Lee DM, et al: A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity re-sulting from tristetraprolin (TTP) deficiency. Immunity 1996; 4(5):445-54.
54. Stumpo DJ, Byrd NA, Phillips RS, et al. Chorioallantoic fusion defects and embryonic lethality resulting from disruption of Zfp36L1, a gene encoding a CCCH tandem zinc finger protein of the Tristetraprolin family. Mol Cell Biol. 2004; 24(14):6445-55.
55. Ramos SB, Stumpo DJ, Kennington EA, et al. The CCCH tandem zinc-finger protein Zfp36l2 is crucial for female fertility and early embryonic development. Dev. 2004; 131(19):4883-93.